175 related articles for article (PubMed ID: 15163756)
1. Herpesvirus protease inhibition by dimer disruption.
Shimba N; Nomura AM; Marnett AB; Craik CS
J Virol; 2004 Jun; 78(12):6657-65. PubMed ID: 15163756
[TBL] [Abstract][Full Text] [Related]
2. Conformational change coupling the dimerization and activation of KSHV protease.
Pray TR; Reiling KK; Demirjian BG; Craik CS
Biochemistry; 2002 Feb; 41(5):1474-82. PubMed ID: 11814340
[TBL] [Abstract][Full Text] [Related]
3. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).
Unal A; Pray TR; Lagunoff M; Pennington MW; Ganem D; Craik CS
J Virol; 1997 Sep; 71(9):7030-8. PubMed ID: 9261433
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements.
Reiling KK; Pray TR; Craik CS; Stroud RM
Biochemistry; 2000 Oct; 39(42):12796-803. PubMed ID: 11041844
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of a viral enzyme by a small-molecule dimer disruptor.
Shahian T; Lee GM; Lazic A; Arnold LA; Velusamy P; Roels CM; Guy RK; Craik CS
Nat Chem Biol; 2009 Sep; 5(9):640-6. PubMed ID: 19633659
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum allosteric inhibition of herpesvirus proteases.
Gable JE; Lee GM; Jaishankar P; Hearn BR; Waddling CA; Renslo AR; Craik CS
Biochemistry; 2014 Jul; 53(28):4648-60. PubMed ID: 24977643
[TBL] [Abstract][Full Text] [Related]
7. Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.
Gable JE; Lee GM; Acker TM; Hulce KR; Gonzalez ER; Schweigler P; Melkko S; Farady CJ; Craik CS
ChemMedChem; 2016 Apr; 11(8):862-9. PubMed ID: 26822284
[TBL] [Abstract][Full Text] [Related]
8. Enzyme inhibition by allosteric capture of an inactive conformation.
Lee GM; Shahian T; Baharuddin A; Gable JE; Craik CS
J Mol Biol; 2011 Sep; 411(5):999-1016. PubMed ID: 21723875
[TBL] [Abstract][Full Text] [Related]
9. One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease.
Nomura AM; Marnett AB; Shimba N; Dötsch V; Craik CS
Biochemistry; 2006 Mar; 45(11):3572-9. PubMed ID: 16533039
[TBL] [Abstract][Full Text] [Related]
10. Auto-inactivation by cleavage within the dimer interface of Kaposi's sarcoma-associated herpesvirus protease.
Pray TR; Nomura AM; Pennington MW; Craik CS
J Mol Biol; 1999 Jun; 289(2):197-203. PubMed ID: 10366498
[TBL] [Abstract][Full Text] [Related]
11. Functional determinants of the Epstein-Barr virus protease.
Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
[TBL] [Abstract][Full Text] [Related]
12. Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.
Acker TM; Gable JE; Bohn MF; Jaishankar P; Thompson MC; Fraser JS; Renslo AR; Craik CS
J Am Chem Soc; 2017 Aug; 139(34):11650-11653. PubMed ID: 28759216
[TBL] [Abstract][Full Text] [Related]
13. Protease dimer formation disrupted.
Chmielewski J
Nat Chem Biol; 2009 Sep; 5(9):607-8. PubMed ID: 19690531
[TBL] [Abstract][Full Text] [Related]
14. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
[TBL] [Abstract][Full Text] [Related]
15. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus ORF17 plays a key role in capsid maturation.
Tsurumi S; Watanabe T; Iwaisako Y; Suzuki Y; Nakano T; Fujimuro M
Virology; 2021 Jun; 558():76-85. PubMed ID: 33735753
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
Chen J; Schaller S; Jardetzky TS; Longnecker R
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
[TBL] [Abstract][Full Text] [Related]
18. A screening strategy for trapping the inactive conformer of a dimeric enzyme with a small molecule inhibitor.
Craik CS; Shahian T
Methods Mol Biol; 2012; 928():119-31. PubMed ID: 22956137
[TBL] [Abstract][Full Text] [Related]
19. Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Li X; Huang L; Xiao Y; Yao X; Long X; Zhu F; Kuang E
J Virol; 2019 May; 93(10):. PubMed ID: 30842327
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase.
González CM; Wang L; Damania B
J Virol; 2009 Oct; 83(19):10224-33. PubMed ID: 19640989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
